Coronavirus treatment developer hopes FDA will fast-track the therapy in US
CytoSorbents CEO Dr. Phillip Chan, MD, discusses his company’s CytoSorb devices which are currently being used on coronavirus patients in China.
via FOX BUSINESS NEWS https://ift.tt/2TXhzD4
No comments:
Post a Comment